Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) 是 tamoxifen 的活性代谢物和选择性雌激素受体(ER)调节剂,广泛用于乳腺癌的治疗和化学预防治疗。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 218 | 现货 | ||
5 mg | ¥ 492 | 现货 | ||
10 mg | ¥ 747 | 现货 | ||
25 mg | ¥ 1,320 | 现货 | ||
50 mg | ¥ 2,160 | 现货 | ||
100 mg | ¥ 3,320 | 现货 | ||
200 mg | ¥ 4,750 | 现货 | ||
500 mg | ¥ 7,290 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 547 | 现货 |
产品描述 | (E/Z)-4-Hydroxytamoxifen (Afimoxifene) is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer. |
靶点活性 | ER: |
体外活性 | 4-OHT is a potent activator of ER and has been shown to have a higher affinity for estrogen receptors compared to tamoxifen. It has significant dose and time-dependent direct effects to alter the contractile function of isolated adult rat cardiac myocytes. 4-HT activates on-target modification frequency for intein-Cas9 variants |
细胞实验 | Cell lines: Adult Rat and Mouse Cardiac MyocytesConcentrations: 0, 0.5, 1, 3, 5, and 10 μMIncubation Time: 15-45 minMethod:For sarcomere length measurements, cells are covered in Tyrode's containing 4OHT, allowed to reach 36 ± 1°C, and then stimulated at 0.2 Hz. |
动物实验 | Animal Models: Sprague-Dawley ratsFormulation: dissolved in 200 μl tricaprylinDosages: 21 mg/kg, 54 μmol/kgAdministration: oral administration |
别名 | 4-羟基他莫昔芬, (E/Z)-4-羟基他莫昔芬, Afimoxifene, 4-Hydroxytamoxifen |
分子量 | 387.51 |
分子式 | C26H29NO2 |
CAS No. | 68392-35-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 71 mg/mL (183.2 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5806 mL | 12.9029 mL | 25.8058 mL | 64.5145 mL |
5 mM | 0.5161 mL | 2.5806 mL | 5.1612 mL | 12.9029 mL | |
10 mM | 0.2581 mL | 1.2903 mL | 2.5806 mL | 6.4514 mL | |
20 mM | 0.129 mL | 0.6451 mL | 1.2903 mL | 3.2257 mL | |
50 mM | 0.0516 mL | 0.2581 mL | 0.5161 mL | 1.2903 mL | |
100 mM | 0.0258 mL | 0.129 mL | 0.2581 mL | 0.6451 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
(E/Z)-4-Hydroxytamoxifen 68392-35-8 Endocrinology/Hormones Estrogen Receptor/ERR Estrogen/progestogen Receptor (E/Z)4Hydroxytamoxifen 4-羟基他莫昔芬 Inhibitor inhibit (E/Z) 4 Hydroxytamoxifen Endogenous Metabolite (E/Z)-4-羟基他莫昔芬 Afimoxifene 4-Hydroxytamoxifen inhibitor